As of the year of 2023, the Cancer Plus was transferred to AccScience Publishing (https://www.accscience.com/journal/CP). Articles starting from Volume 5 Issue 1 (2023) will be published by AccScience Publishing, while articles from Volume 1 Issue 1 (2019) to Volume 4 Issue 3 (2022) that were previously published by Whioce Publishing will be hosted by AccScience Publishing as a courtesy and upon the agreement with Whioce Publishing, with the original distribution license being applied. Articles that have been planned to be released as Online First articles will be released and published as such by AccScience Publishing. Please contact the Editor-in-Chief for information regarding the new publisher and any submissions in progress.
Inhibition of cancer cell proliferation by adenosine triphosphate-triggered codelivery system of p53 gene and doxorubicin
Fight for men’s health: Call of bladder cancer and prostate cancer screening